Adicet Bio CEO Chen Schor's 2022 pay falls 59% to $4M
Adicet Bio reports 2022 executive compensation
By ExecPay News
Published: April 18, 2023
Adicet Bio reported fiscal year 2022 executive compensation information on April 18, 2023.
In 2022, three Adicet Bio executives received on average a compensation package of $2.8M, a 42% decrease compared to previous year.
Chen Schor, Chief Executive Officer, received $4M in total, which decreased by 59% compared to 2021. 77% of Schor's compensation, or $3.1M, was in option awards. Schor also received $310K in non-equity incentive plan, $562K in salary, as well as $28K in other compensation.
Blake Aftab, Chief Scientific Officer, received a compensation package of $2.5M. 73% of the compensation package, or $1.8M, was in option awards.
Francesco Galimi, Chief Medical Officer, earned $2M in 2022, a 15% decrease compared to previous year.